Collection, monitoring and evaluation of safety data is a key responsibility of the Sponsor and Investigator and the first goal listed by the FDA. Adverse events and serious adverse events are key data elements to review the safety of a product. An adverse event is defined as an untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product that does not necessarily have a causal relationship with this treatment. This course will introduce you to common safety monitoring practices and the regulatory reporting responsibilities for medical products.
|Dates||Days and Times||Location||Faculty|
|7/13/20-8/3/20||Mon, 6:00PM-7:30PM||Online||Bethany Van Veen|
Course fee: $310
|Refund Code||Full Refund||75% Refund||No Refund|
|CEL_2SUM||Class dropped one day prior to class start day||Class dropped on class start day||Class dropped beyond class start day|
Last Update: Apr 03, 2020 9:45am